Depression Severe
12
5
7
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.3%
1 terminated out of 12 trials
66.7%
-19.8% vs benchmark
17%
2 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
Brain Stimulation for Severe Depression
Telehealth Behavioral Activation for Teens
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Kintsugi Voice Device Pivotal Study
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
Kintsugi Voice Device Pilot Study
Integrated Depression Care
Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Exercise Recovery From Persistent Depression: A Thematic Analysis
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department